Trials / Completed
CompletedNCT07269704
Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease
Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease: An Open Label, Single Arm Study to Evaluate the Effect of Alpha-ketoglutarate Administered Orally in Patients With Age-related Ocular Diseases (Metabolic Eye Therapy)
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aims of the study are as follows: 1. Determine how the eye absorbs supplements taken orally. 2. Look for specific signs in the proteins and substances in the eyes of people with eye diseases who are also taking nutritional supplements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium alpha-ketoglutarate | Participants took 2 g/day of calcium alpha-ketoglutarate orally, twice daily, for 7 days. |
Timeline
- Start date
- 2023-08-15
- Primary completion
- 2025-06-10
- Completion
- 2025-06-10
- First posted
- 2025-12-08
- Last updated
- 2026-04-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07269704. Inclusion in this directory is not an endorsement.